Press release
Drug Eluting Balloon Catheter Market in Europe to Remain Highly Attractive || Key Players: Tokai Medical Products Inc., BIOTRONIK SE & Co. KG, B. Braun Melsungen AG
The emergence of new-generation drug eluting balloon catheters have opened avenue for stakeholders and manufacturers in the market. Moreover, in order to accentuate its utility, massive investments in research and development pipelines have been witnessed. Growing number of companies are gradually shifting towards manufacturing drug eluting balloon catheters as it has turned out be viable and efficient vis-à-vis balloon angioplasty or stenting.
Request Sample Here:
https://www.factmr.com/connectus/sample?flag=S&rep_id=146
A lately compiled research analysis on the drug eluting balloon catheter market unveil that ever-increasing healthcare expenditure, burgeoning geriatric demographic, enhanced reimbursement support by governments will account for the augmentation of the drug eluting balloon catheter.
However, DEB do face daunting challenge rom drug eluting stents (DES) for the treatment of coronary artery disease. Though clinical application of drug eluting stents has significantly lessened the incidence of in-stent restenosis, delayed stent thrombosis and malapposition does not augur fare well with DES. On account of complications associated with DES, drug eluting balloon catheter was designed to negate insertion of a permanent foreign object in the blood vessel.
By indication, the coronary artery disease will continue to hold its dominant position over 2022. The segment currently accounts for around 83% share of the market in terms of value. Towards the end of the forecast period, this segment is expected to surpass a market valuation of US$ 378 Mn in 2022, reflecting a robust CAGR.
By end user, the hospital segment is expected to retain its predominant position over the assessment period. In terms of revenue, the segment accounts for around 73% share of the market. By 2022-end, the hospital segment is expected to reach a market valuation of over US$ 333 Mn.
Drug Eluting Balloon Catheter Market: Overview
The report provides an exhaustive analysis on the market for drug eluting balloon catheter for the assessment period 2018-2026. The report further sheds light on the dynamics of the drug eluting balloon catheter market which significantly impact the growth of the market.
Furthermore, the report delves into the segregation of the market which is will provide readers with an actionable insights which will aid them in taking proper decision based on segments historical and future growth estimates.
Browse Full Report with TOC:
https://www.factmr.com/report/146/drug-eluting-balloon-catheter-market
The report also focuses on the epidemiology and product mapping behavior on the basis of region. The report also incorporates average pricing analysis and sheds light on supply chain. Assessment of the drug eluting balloon catheter market incorporates provision of relevant market numbers and regional assessment of major factors. The report also includes regional and country-wise assessment.
A robust research methodology has been adopted for the forecast and assessment on the drug eluting balloon catheter market. The research sources include primary and secondary sources which have been further examined by in-house panel of experts. The market size of the drug eluting balloon catheter is the result of revenue comparison, market share comparison and Y-o-Y growth comparison on the geography.
Drug Eluting Balloon Catheter Market: Competitive Landscape
Prominent market players being instrumental in the growth of the drug eluting balloon catheter market are profiled and assessed on the basis of company overview, financial overview, product offering, recent development, key differentiators and strategies. The report also includes SWOT analysis as well as gives insights on drug eluting balloon catheter market indication list and the drug eluting balloon catheter market indication sales data and key financials.
Cardionovum GmbH, Cook Medical INC, Cordis Corporation, Abbott Laboratories, Meril Life Sciences Pvt Ltd, Jotech GmbH, MicroPort Scientific Corporation, Terumo Corporation, Boston Scientific Corporation, Tokai Medical Products Inc., BIOTRONIK SE & Co. KG, B. Braun Melsungen AG, and Medtronic Plc. are the leading companies profiled in Fact.MR’s report.
Analysis of the major market players becomes indispensable as it will succor readers to make proper decision to enlarge their business and can comprehend strategic moves made by prominent players in the drug eluting balloon catheter market.
For More Information Raise Enquiry:
https://www.factmr.com/connectus/sample?flag=AE&rep_id=146
About Fact.MR
Fact.MR is a fast-growing market research firm that offers the most comprehensive suite of syndicated and customized market research reports. We believe transformative intelligence can educate and inspire businesses to make smarter decisions. We know the limitations of the one-size-fits-all approach; that's why we publish multi-industry global, regional, and country-specific research reports.
Contact Us
Fact.MR
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
sales@factmr.com
www.factmr.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Drug Eluting Balloon Catheter Market in Europe to Remain Highly Attractive || Key Players: Tokai Medical Products Inc., BIOTRONIK SE & Co. KG, B. Braun Melsungen AG here
News-ID: 1688194 • Views: …
More Releases from Fact.MR
Bagless Vacuum Cleaners Market Is Predicted To Touch US$ 39.52 Billion By 2033: …
The global demand for bagless vacuum cleaners is forecasted to experience a compound annual growth rate (CAGR) of 8% from 2023 to 2033. Consequently, the market for bagless vacuum cleaners worldwide is anticipated to surge from a value of US$ 18.3 billion in 2023 to reach US$ 39.52 billion by the end of 2033.
The Bagless Vacuum Cleaner Industry sales study offers a comprehensive analysis on diverse features including production…
NFC Chips Are Predicted To Reach US$ 7.6 Billion At A CAGR Of 15% By 2033: Fact. …
The global NFC chip market is valued at US$ 1.9 billion in 2023 and is forecasted to surge at a CAGR of 15% to reach a market size of US$ 7.6 billion by the end of 2033.
The NFC Chip Industry sales study offers a comprehensive analysis on diverse features including production capacities, NFC Chip demand, product developments, sales revenue generation and NFC Chip market outlook across the globe.
market research…
Canned Beans Market Is Anticipated To Reach US$ 15 Billion By 2033: Fact.MR Repo …
The global canned beans market is valued at US$ 5.65 billion in 2023 and is projected to reach US$ 15 billion by the end of 2033, expanding at a high-value CAGR of 10.3% from 2023 to 2033.
The Canned Beans Industry sales study offers a comprehensive analysis on diverse features including production capacities, Canned Beans demand, product developments, sales revenue generation and Canned Beans market outlook across the globe.
market research…
Plasma Fractionation Market Projected to Reach US$ 65 Billion by 2032, With 7.3% …
The plasma fractionation market is projected to be valued US$ 32 billion in 2022. Moreover, growth is anticipated to pick up speed at a 7.3% CAGR over the assessment period of 2022-2032 and reach US$ 65 billion. The primary driver of the market's growth is the aging of the global population, which makes people more vulnerable to rare illnesses that call for the usage of blood derivatives.
Furthermore, it is anticipated…
More Releases for Drug
Alcohol Testing And Drug Testing Equipment Market 2025 Segmentation, Application …
Market Study Report, LLC, has compiled an exhaustive research study of the ‘Alcohol Testing And Drug Testing Equipment market’, detailing every single market driver and intricately analyzing the business vertical. This ‘Alcohol Testing And Drug Testing Equipment market’ study will aid in seeking out new business opportunities and fine-tuning existing marketing strategies through insights regarding SWOT analysis, market valuation, competitive spectrum, regional share, and revenue predictions.
Alcohol abuse and drug…
How much Diabetes Drug Market Impact Worldwide Medical Drug Industry?
Diabetes Drug Market From an insight perspective, the market report focuses on various levels of analyses — industry analysis, market rank analysis, and company profiles, which together comprise and discuss basic views on the competitive landscape, high-growth regions, and countries as well as their respective regulatory policies, Types ,Applications and opportunities in the market.
Diabetes is a metabolic disorder in which the body glucose level is elevated. There are two types of diabetes…
Hepatitis Drug Market Hepatitis Drug Clinical Pipeline Report 2023
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990
Report Table of Contents
1. Introduction to Hepatitis Disease
1.1 Prologue
1.1.1 History of Hepatitis
1.1.2 Causes of Hepatitis Disease
1.2 Types of Viruses which are Responsible for Hepatitis Disease
2. Global Prevalence of Hepatitis Infection
3. Available Drug Classes for Hepatitis Disease Treatment
3.1 Interferon Alfa Therapy
3.2 Protease Inhibitors Therapy
3.3 Polymerase…
Microcapsules Drug Delivery Market Microcapsules Drug Delivery Sales Report 2022
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990
Report Table of Contents
1. Indispensable Advent of Microcapsules
1.1 Trajectory of Microencapsulation
1.2 Why and wherefores for Microencapsulation
2. Characterization of Microcapsules
2.1 Composition of Microcapsules
2.2 Parameters Influencing Microcapsules
3. Engineering Technology of Microcapsules
3.1 Physical Manufacturing Technologies
3.2 Physicochemical and Chemical Technologies
4. Applicability of Microcapsules
4.1 Microcapsules in Pharmaceuticals
4.2 Microcapsules in Nutraceuticals
…
AstraZeneca’s NMOSD Drug receives orphan drug designation
April 18, 2017 Orphan Drug
European Medicine Agency has Announced orphan drug designation for inebilizumab (earlier known as MEDI-551) developed by AstraZeneca PLC (AZN) for the treatment of neuromyelitis optica spectrum disorder (NMOSD). The drug has already received orphan drug status from US Food and Drug Administration (FDA). NMOSD, also called Devic’s disease, is a rare, autoimmune disorder of the central nervous system (CNS) that affects the functioning…
Drug Discovery Strategies, PBPK Modeling and Drug-Drug Interaction Explored and …
This year’s 12th annual ADMET conference and exhibition promises to deliver appearances from experienced pharmaceutical professionals from ADME and PK/PD organisations such as AbbVie, GSK, Roche and Bayer when it returns to London this June.
The carefully selected speaker line up will be addressing early ADME application strategies and discussing the latest technologically advanced screening and testing models along with exploring ADMET technologies which will identify properties of a drug…
